Myofascial pain syndrome in upper trapezius muscle. Other primary disorders of muscles
Conditions
Interventions
Intervention 1: Control group: Only for comparison with intervention group, no treatment is performed. Intervention 2: Intervention group 1: 25 patients will be treated with dry needles according to t
Treatment - Other
Rehabilitation
Control group: Only for comparison with intervention group, no treatment is performed.
Intervention group 1: 25 patients will be treated with dry needles according to the protocol (sterile epoxy needles 0.3 mm in diameter and 5 cm in length). Each point will be treated for 2 minutes. Tr
Intervention group 2: 25 people are treated with an inhibitive movement tape according to the protocol (5 cm bandwidth). The muscle will be measured in its longitudinal position (the neck will bend to
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Women 20 to 40 years Having chronic pain that lasts at least 3 months from the start The presence of tight band in the muscle Having sensitive points in the upper trapezius muscle Recognizing pain
Exclusion criteria
Exclusion criteria: Individuals with fibromyalgia Individuals with Facial Nerve Neuralgia, Rheumatoid Arthritis, Rheumatic Diseases, Degenerative Diseases, Fractures, Dislocation, Inflammation, Bursitis and Arthritis Persons with Neck and Shoulder Myopathy, Neuropathy, Myelopathy and Cortical People with history of neck and shoulder surgery and other areas of the body People with a history of injection in the trigger points of upper trapezius muscle or acupuncture People with cancer, Infection, Pain and Pathogenesis, Acquired Immunodeficiency virus Athletes people with substance abuse or taking corticosteroid drugs as well as pregnant women Those who have undergone continuous physiotherapy or exercise during the last two weeks Those who received dry needles in the last three months Taking sedative medications or alcohol one week prior to evaluation People with mental and cognitive impairment and uncorrected vision impairment People with acrylic skin allergies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle thickness. Timepoint: Before and after the intervention. Method of measurement: Sonography.;Intensity of pain. Timepoint: Before and after the intervention. Method of measurement: Visual Analogue Scale (VAS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSirous Taghizadeh-Delkhosh
Semnan University of Medical Sciences
Outcome results
None listed